New regulatory co-receptors: inducible co-stimulator and PD-1.
about
Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cellsRisk factors and primary prevention trials for type 1 diabetesSpecific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisThe DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responsesInefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infectionPD-1 regulates neural damage in oligodendroglia-induced inflammation.The use of immunotherapy in the treatment of melanomaOctamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from UgandaEstablishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cellsEBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted functionCostimulatory pathways in transplantation.Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques.Sequence, structure, function, immunity: structural genomics of costimulation.Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.Inhibition of T-cell activation by syndecan-4 is mediated by CD148 through protein tyrosine phosphatase activity.Immune regulatory mechanisms influence early pathology in spinal cord injury and in spontaneous autoimmune encephalomyelitis.Immune checkpoint blockade and interferon-α in melanoma.Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasisDC-HIL is a negative regulator of T lymphocyte activation.CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotypeImmunotherapy for pancreatic cancer - science driving clinical progress.Cancer immunotherapy: Progress and challenges in the clinical setting.Molecules involved in T-B co-stimulation and B cell homeostasis: possible targets for an immunological intervention in autoimmunity.PD-1/PD-L pathway and autoimmunity.In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responsesThe challenge of inhibiting alloreactive T-cell memory.CD4+CD25+ regulatory T cells in health and disease.The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome.Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapyTLR-mediated induction of negative regulatory ligands on dendritic cells.Targeting of the immune system in systemic lupus erythematosus.Regulation of B cell tolerance by 129-derived chromosome 1 loci in C57BL/6 mice.
P2860
Q24796946-9AF1BA92-53B7-401A-9D2A-81FE23248A50Q27005625-A17AE4D1-5B27-4B11-B5EF-23F5E7DC2113Q28074434-6E1D4A92-9EEB-4D79-A2E7-243CD5ADE2A5Q28114771-B9ABEE9B-2932-4E15-A793-79DE52234844Q33352696-BFA4038A-3330-4E71-9258-32DE00B0868FQ33406287-90FA237E-F004-4E7A-9EBA-532DDF34620FQ33593858-C55AEBD4-3610-4BCD-B473-D8106E71ECE1Q33601667-06B0D336-98D8-4BE0-A76D-4676E8871114Q33805240-90119FBE-55CF-495D-9216-AEA174592333Q33920287-B8191122-AC60-4B68-B750-F0A6F5E39734Q34001061-2B99A887-467C-4F13-8AE4-99641B2DCC23Q34186560-F4608E7C-1E9C-49DF-B05C-BDE90E60154FQ34187594-BF11A9E2-93AF-4ADA-A805-CF48B803C724Q34377004-28E8ED51-349D-44D0-90EE-5E46C2F2BFDCQ34401723-39D1921D-4271-4A46-BFBC-7A90383B512AQ34514517-80E88D59-0D46-4D3E-8E24-35D3B5F6EFFEQ34543002-01393358-EE8C-40DA-AF65-B1D7CC831E51Q34554699-F82DD187-42BB-4513-9B1A-89EAFE14046FQ34570624-939C0D81-5EA4-4751-87E7-34F48EB89EECQ34606735-E177659D-FC8C-4A51-906F-9A5D2E590C47Q34650346-F0184ED0-6523-459F-ABE5-0C676D47A893Q34720087-9FE6FF80-EA8E-4072-B71D-6F750522E878Q35082927-603F8A62-21D0-4EA7-A453-413DBA7419BFQ35083879-584D2008-914A-4FFB-84DE-AC91AD54EA08Q35598991-E656B98B-48F2-4DD6-8CE8-7418E93CD08FQ35750880-DCDD91E8-9345-4DC7-A557-D8CBC61E70F3Q35828672-5AA1ED5D-2BFA-46B7-9C3A-61620D609C78Q35828831-E76E9345-B9A1-451A-B386-48B5B64843DEQ36133140-506422E5-7B7B-4B7B-8C66-37382A4B384DQ36184314-1A22CFDC-5F4A-4F04-A536-50D5A4B410DCQ36269623-F4C6DFDA-761E-42DD-834E-FBFEFAB2AAF5Q36287532-5FFA8811-9B12-4EB4-9B9A-50E505F2E9F3Q36402989-4CB91D85-B93F-4401-A1CA-1EB3370CF9D6Q36422118-BA80FE0D-2B0F-471C-9A10-4856D60A15A3Q36478841-538EECC6-043D-4CB3-8B20-AC09C97056E6Q36483852-3543AC60-71D2-4FCF-A951-9851AAA1CB51Q36692284-AFFFE096-5088-477C-BE22-9CD389817C29Q36914835-9F04873D-696C-4D7B-B843-35ABE06BBA67Q37060593-CDE30884-F88B-46D3-AA9D-D8DB9B117307Q37134291-6B24055B-552F-40D5-858B-C9A14E889806
P2860
New regulatory co-receptors: inducible co-stimulator and PD-1.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New regulatory co-receptors: inducible co-stimulator and PD-1.
@ast
New regulatory co-receptors: inducible co-stimulator and PD-1.
@en
New regulatory co-receptors: inducible co-stimulator and PD-1.
@nl
type
label
New regulatory co-receptors: inducible co-stimulator and PD-1.
@ast
New regulatory co-receptors: inducible co-stimulator and PD-1.
@en
New regulatory co-receptors: inducible co-stimulator and PD-1.
@nl
prefLabel
New regulatory co-receptors: inducible co-stimulator and PD-1.
@ast
New regulatory co-receptors: inducible co-stimulator and PD-1.
@en
New regulatory co-receptors: inducible co-stimulator and PD-1.
@nl
P1476
New regulatory co-receptors: inducible co-stimulator and PD-1.
@en
P2093
Taku Okazaki
Yoshiko Iwai
P304
P356
10.1016/S0952-7915(02)00398-9
P50
P577
2002-12-01T00:00:00Z